Vivione Biosciences signs agreement with CMS Technology

LITTLE ROCK, AR, April 15, 2014 – Vivione Biosciences, Inc. (TSX:VBI), through its wholly owned subsidiary, Vivione Biosciences, LLC, announced the signing of a definitive Purchase Agreement for the RAPID B system from CMS Technology, Inc., (“CMS”) a New York-based firm focused on developing and delivering cost-effective, innovative solutions to mitigate pathogen risks in food, packaging and material applications.
Read more here.